Patrick J. Kennedy, former US Representative for Rhode Island's 1st Congressional District, says that he authored the Mental Health Parity & Addictions Equity Act in 2008, which was then incorporated into the Affordable Care Act in 2010. The parity law went into effect in January 2014, and by 2015, more health plans are expected to be covered under it.
Patrick J. Kennedy, former US Representative for Rhode Island's 1st Congressional District, says that he authored the Mental Health Parity & Addictions Equity Act in 2008, which was then incorporated into the Affordable Care Act in 2010. The parity law went into effect in January 2014, and by 2015, more health plans are expected to be covered under it.
“What I’m interested in is working with the insurance community to really develop a process by which we get a consensus on what it is that constitutes mental health,” says Mr Kennedy. “The way we do that is we bring in both providers—and most importantly the consumers—with the insurance industry and really have an open discussion about what works, and if it works, then obviously we want it paid for.”
He adds that investing in mental health not only saves costs for those with chronic diseases such as diabetes and cardiovascular disease, but for a variety of budgets affected by healthcare spending.
“What we need to do is have a much bigger picture of what it is that we need to construct in terms of the financial package that will allow us to truly build out the services that will treat these biopsychosocial recovery models,” says Mr Kennedy. “It’s going to take all—it’s going take the bio, the medical, it’s going to take the social, it’s going to take the mental health—all of them tied together to really achieve the savings that we know are there if people are managed much more effectively in terms of their illnesses playing havoc in their lives.”
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
EHA Plenary Abstracts Zoom in From Investigational Drugs to Molecular Signatures
June 14th 2025Abstracts presented during the plenary session of the 2025 European Hematology Association (EHA) Congress spanned from novel drug regimens for myeloma and lymphoma to investigation of leukemias on the molecular and genetic levels.
Read More
COVID-19 Deaths Cloud Interpretation of Acalabrutinib-Venetoclax Combo Results
June 13th 2025A combination of acalabrutinib and venetoclax showed better results with the addition of obinutuzumab, whereas mixed findings in a cross-trial comparison were complicated by the inclusion of deaths related to COVID-19.
Read More